|
|
Rupert Kaul, Tao Dong, Francis A. Plummer, Joshua Kimani, Timothy Rostron, Peter Kiama, Ephantus Njagi, Erastus Irungu, Bashir Farah, Julius Oyugi, Rana Chakraborty, Kelly S. MacDonald, Job J. Bwayo, Andrew McMichael, Sarah L. Rowland-Jones
J Clin Invest. 2001;
107(10):1303
doi:10.1172/JCI12433
Abstract |
Full text
| PDF

H
IV-1–specific cytotoxic T-lymphocyte (CTL) responses have been detected at a low frequency in many HIV-1–exposed, persistently seronegative (HEPS) subjects. However, it is unclear how CTLs could protect against HIV acquisition in HEPS subjects, when high levels of circulating CTL fail to prevent disease progression in most seropositive subjects. To address this issue we studied CD8+ lymphocyte responses to a panel of HIV-1 CTL epitopes in 91 HEPS and 87 HIV-1–infected Nairobi sex workers. HIV-specific responses in seropositive women focused strongly on epitopes rarely or never recognized in HEPS subjects, who targeted epitopes that were subdominant or unrecognized in infected women. These differences in epitope specificity were restricted by only those HLA class I alleles that are associated with a reduced risk of HIV-1 infection in this cohort. Late seroconversion in HEPS donors was associated with a switch in epitope specificity and/or immunodominance to those epitopes preferentially recognized by HIV-1–infected women. The likelihood of detecting HIV-1–specific responses in HEPS women increased with the duration of viral exposure, suggesting that HIV-1–specific CD8+ responses are acquired over time. The association between differential recognition of distinct CTL epitopes and protection from HIV-1 infection may have significant implications for vaccine design.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(13)
| Title and authors |
Publication |
Year |
The Immune System and Resisting HIV Infection
Keith R. Fowke, Catherine M. Card, Rupert Kaul
|
Models of Protection Against HIV/SIV
|
2012 |
CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend
Kevin H. Kim, William W. Greenfield, Martin J. Cannon, Hannah N. Coleman, Horace J. Spencer, Mayumi Nakagawa
|
Cancer Immunol Immunother
|
2012 |
HIV vaccine candidates generate in vitro T cell response to putative epitopes in Chinese-origin rhesus macaques
Qi Liao, Amie J. Strong, Ying Liu, Yanhou Liu, Peng Meng, Yang Fu, Neal Touzjian, Yiming Shao, Zhongfang Zhao, Yichen Lu
|
Vaccine
|
2012 |
Comparative antiviral activity of integrase inhibitors in human monocyte-derived macrophages and lymphocytes
Fernanda Scopelliti, Michela Pollicita, Francesca Ceccherini-Silberstein, Fabiola Di Santo, Matteo Surdo, Stefano Aquaro, Carlo-Federico Perno
|
Antiviral Research
|
2011 |
A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses
Mauro S. Malnati, Silvia Heltai, Antonio Cosma, Peter Reitmeir, Simone Allgayer, Richard H. Glashoff, Walter Liebrich, Eftyhia Vardas, Nesrina Imami, Samantha Westrop
|
Journal of Immunological Methods
|
2011 |
Factores que influyen en la resistencia a la infección por el virus de la inmunodeficiencia humana
Clara Restrepo, Norma Ibón Rallón, José Miguel Benito
|
Medicina Clínica
|
2011 |
Highly avid, oligoclonal, early-differentiated antigen-specific CD8+ T cells in chronic HIV-2 infection
Aleksandra Leligdowicz, Clayton Onyango, Louis-Marie Yindom, YanChun Peng, Matthew Cotten, Assan Jaye, Andrew McMichael, Hilton Whittle, Tao Dong, Sarah Rowland-Jones
|
Eur. J. Immunol.
|
2010 |
Viral fitness implications of variation within an immunodominant CD8+ T-cell epitope of HIV-1
N.M. Christie, D.O. Willer, M.A. Lobritz, J.K. Chan, E.J. Arts, M.A. Ostrowski, A. Cochrane, M.A. Luscher, K.S. MacDonald
|
Virology
|
2009 |
Differential immunogenicity of vaccinia and HIV-1 components of a human recombinant vaccine in mucosal and blood compartments.
Peter A Anton, F Javier Ibarrondo, W John Boscardin, Ying Zhou, Elissa J Schwartz, Hwee L Ng, Mary Ann Hausner, Roger Shih, Julie Elliott, Patricia M Hultin, Lance E Hultin, Charles Price, Marie Fuerst, Amy Adler, Johnson T Wong, Otto O Yang, Beth D Jamieson
|
Vaccine
|
2008 |
Not just sheer luck! Immune correlates of protection against HIV-1 infection
Luca Piacentini, Claudio Fenizia, Valentina Naddeo, Mario Clerici
|
Vaccine
|
2008 |
|